Confirmation of a Rare Genetic Leukoencephalopathy due to a Novel Bi-allelic Variant in RPIA

Eur J Med Genet. 2019 Aug;62(8):103708. doi: 10.1016/j.ejmg.2019.103708. Epub 2019 Jun 25.

Abstract

Ribose 5-phosphate isomerase deficiency is a rare genetic leukoencephalopathy caused by pathogenic sequence variants in RPIA, that encodes ribose 5-phosphate isomerase, an enzyme in the pentose phosphate pathway. Till date, only three individuals with ribose 5-phosphate isomerase deficiency have been described in literature. We report on a subject with RPIA associated progressive leukoencephalopathy with elevated urine arabitol and ribitol levels and a novel missense variant c.770T > C p.(Ile257Thr) in exon 8 of RPIA. We also compare the phenotypes of all the four subjects. Our report confirms the phenotype and the genetic cause of this condition.

Keywords: Epilepsy; Leukoencephalopathy; Pentose phosphate pathway; RPIA; Ribose 5-phosphate isomerase deficiency.

Publication types

  • Case Reports

MeSH terms

  • Aldose-Ketose Isomerases / deficiency*
  • Aldose-Ketose Isomerases / genetics
  • Alleles
  • Carbohydrate Metabolism, Inborn Errors / drug therapy
  • Carbohydrate Metabolism, Inborn Errors / genetics*
  • Carbohydrate Metabolism, Inborn Errors / pathology
  • Humans
  • Leukoencephalopathies / drug therapy
  • Leukoencephalopathies / genetics*
  • Leukoencephalopathies / pathology
  • Male
  • Pentose Phosphate Pathway / genetics
  • Polyneuropathies / drug therapy
  • Polyneuropathies / genetics*
  • Polyneuropathies / pathology
  • Ribitol / administration & dosage
  • Sugar Alcohols / administration & dosage

Substances

  • Sugar Alcohols
  • Ribitol
  • Aldose-Ketose Isomerases
  • ribosephosphate isomerase
  • arabitol

Supplementary concepts

  • Ribose 5-Phosphate Isomerase Deficiency